Enzyme Replacement Therapy of Fabry Disease

Author： Clarke Joe T. R.   Iwanochko R. Mark  

Publisher： Humana Press, Inc

ISSN： 0893-7648

Source： Molecular Neurobiology, Vol.32, Iss.1, 2005-08, pp. : 43-50

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in the management of Anderson–Fabry disease:enzyme replacement therapy

By Thadhani Ravi   Pastores Gregory M  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 3, 2002-03 ,pp. : 325-333

Informa Healthcare

Access to resources Recommend Favorite

Production in yeast of α -galactosidase A, a lysosomal enzyme applicable to enzyme replacement therapy for Fabry disease

By Chiba Yasunori  

Glycobiology, Vol. 12, Iss. 12, 2002-12 ,pp. : 821-828

Oxford University Press

Access to resources Recommend Favorite

Enzyme replacement therapy for Fabry disease: lessons from two α-galactosidase A orphan products and one FDA approval

By Desnick Robert J  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 7, 2004-07 ,pp. : 1167-1176

Informa Healthcare

Access to resources Recommend Favorite

Enzyme replacement therapy for Gaucher disease

By Charrow Joel  

Expert Opinion on Biological Therapy, Vol. 9, Iss. 1, 2009-01 ,pp. : 121-131

Informa Healthcare

Access to resources Recommend Favorite

A biochemical and pharmacological comparison of enzyme replacement therapies for the glycolipid storage disorder Fabry disease

By Barngrover D.   Lee K.   McPherson J.M.   Jin X.   Edmunds T.   Zhang K.   Copertino L.   Andrews L.   Baker-Malcolm J.   Geagan L.   Qiu H.   Seiger K.  

Glycobiology, Vol. 13, Iss. 4, 2003-04 ,pp. : 305-313

Oxford University Press

Access to resources Recommend Favorite